Related references
Note: Only part of the references are listed.Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System
A. H. Hautmann et al.
BONE MARROW TRANSPLANTATION (2013)
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
S-E Lee et al.
BONE MARROW TRANSPLANTATION (2013)
Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease
Nikolaus Rieber et al.
JOURNAL OF IMMUNOLOGY (2013)
The plasticity and stability of regulatory T cells
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
Claudia A. Dumitru et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells
Sara M. Centuori et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children
Evgenios Goussetis et al.
TRANSFUSION AND APHERESIS SCIENCE (2012)
Extracorporeal Photopheresis Attenuates Murine Graft-versus-Host Disease via Bone Marrow-Derived Interleukin-10 and Preserves Responses to Dendritic Cell Vaccination
Christian M. Capitini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis
Robert Whittle et al.
BLOOD (2011)
Extracorporeal Photopheresis: How, When, and Why
David M. Ward
JOURNAL OF CLINICAL APHERESIS (2011)
Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease
E. Merlin et al.
TRANSPLANT IMMUNOLOGY (2011)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The growing diversity and spectrum of action of myeloid-derived suppressor cells
Alberto Mantovani
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
Leif E. Sander et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease
Zoya Kuzmina et al.
BLOOD (2009)
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
Afonso C. Vigorito et al.
BLOOD (2009)
Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma
E. Bisaccia et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Extracorporeal photopheresis: what is it and when should it be used?
J. Scarisbrick
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells
Chang-Qing Xia et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Extracorporeal photoimmunotherapy-photopheresis
Theresa Dani et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Extracorporeal photopheresis: Past, present, and future
Robert Knobler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Extracorporeal Photopheresis Efficiently Impairs the Proinflammatory Capacity of Human 6-Sulfo LacNAc Dendritic Cells
Michael Gerner et al.
TRANSPLANTATION (2009)
Regulatory T Cells and Extracorporeal Photochemotherapy: Correlation With Clinical Response and Decreased Frequency of Proinflammatory T Cells
Iolanda Di Biaso et al.
TRANSPLANTATION (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
Erin Gatza et al.
BLOOD (2008)
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2008)
Role for CD4+CD25+ T cells in inhibition of graft rejection by extracorporea photopheresis
James F. George et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+functional regulatory T-cells in patients with graft-versus-host disease
Ettore Biagi et al.
TRANSPLANTATION (2007)
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients
F. Meloni et al.
TRANSPLANTATION PROCEEDINGS (2007)
Extracorporeal photopheresis: A focus on apoptosis and cytokines
J. Bladon et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
The immunological effects of extracorporeal photopheresis unraveled: Induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
A Lamioni et al.
TRANSPLANTATION (2005)
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
ED Seaton et al.
BLOOD (2003)
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun et al.
BLOOD (2002)